|
 |
 |
Preclinical Immunogenicity Assessment
Protein therapeutics can potentially elicit immune responses when administered in humans. These antidrug antibodies could result in partial or complete loss of drug efficacy and other complications that have the potential to cause severe adverse effects in the patient. In this webcast, Philippe Stas, Head of Applied Protein Services at Lonza, demonstrates how preclinical immunogenicity assessment can help mitigate these risks and produce safer and more cost-effective protein therapeutics. More. |
 A Novel Filtration System Used to Intensify Upstream and Downstream Operations
Want to improve your bioprocess? Used in various bioprocessing applications, ATF™ System from Refine Technology provides a more reliable and efficient process of cell separation with the inherent ability to support cell growth to extreme concentrations. In this webcast, John Bonham-Carter, VP of Sales and Business Development at Refine Technology, provides a detailed look at the ATF System, its applications and its benefits. More.
 Quality, Speed and Flexibility by Design
Accelerating the path to new biomanufacturing capacity typically corresponds with increased costs and the risk of lower quality. Overcoming these compromises requires a holistic QbD-based rethinking of how biomanufacturing is approached. By rethinking biomanufacturing equipment, facility design and services, Xcellerex has achieved dramatic improvements in deployment time, while also reducing capital investment, operating costs, and improving overall quality and compliance. View this informative webcast to learn more about the Xcellerex FlexFactory® Biomanufacturing Platform. More.
Industrial Purification with Convective Interaction Media™ Monoliths
Monoliths offer a unique set of characteristics that, when properly applied, can significantly improve the overall productivity of the manufacturing processes. In this educational webcast, Tony Brazalle of BIA Separations explores the technology behind the BIA Separations CIM™ Monolithic Columns. Join Tony as he demonstrates the many benefits of monoliths, such as improved process economics, increased facility capacity, reduced COGS and more. More.
 Technology Transfer of CMC Activities for MAb Manufacturing
As monoclonal antibody products succeed and advance through development, their manufacturing requirements change. The probability of a smooth and successful technology transfer process depends on several factors. Sending and receiving parties must be well aligned in expectations, which can be facilitated by early and detailed planning and communications. Click here to learn more about the complex steps necessary to successfully advance new MAbs from discovery to first-in-human clinical trials and the market as quickly and economically as possible.
|
 |
 |
 |
 |
|
|
|
|
Measuring Manufacturing Cost and Its Impact on Organizations
BioProcess International, June 2010
Read more.
How Geography Affects the Cost of Biomanufacturing
BioProcess International, June 2010
Read more.
Flexible Manufacturing
BioProcess International, May 2010
Read more.
A Smarter Approach to Biomanufacturing
BioProcess International, May 2010
Read more.
Road Map to Implementation of Single-Use Systems
BioProcess International, April 2010
Read more.
Changes in Raw Material Sources from Suppliers
BioProcess International, April 2010
Read more.
Delivering Affordable Biologics from Gene to Vial
BioProcess International, March 2010
Read more.
|
|
|
|
|
|
